Also worthy of consideration is that the introduction of insulin self-injection pens for patients with diabetes led to an improvement in patient compliance and treatment outcomes, with patients reporting that they found injection pens less painful than syringes and needles [17-22]. The gene discussed is INS; the disease is diabetes mellitus.